✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Alnylam Pharmaceuticals Inc

Common Name
Alnylam Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,500
Ticker
ALNY
Exchange
NASDAQ/NGS
Description
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing RNA interference (RNAi) therapeutics. This innovative gene silencing technology targets the root ca...

Alnylam Pharmaceuticals's Board Composition Data

Explore Alnylam Pharmaceuticals's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.

Metric2026/3/1
Total Board Members
10a
Executive Board Members
1a
Non-Executive Board Members
9a
Independent Board Members
9a
Non-Independent Board Members
1a
Female Board Members
4a
Male Board Members
6a
Non-Binary Board Members
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Alnylam Pharmaceuticals’s Board Composition Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Alnylam Pharmaceuticals's DEF 14A 2025